The present invention relates to the field of pharmaceutical technology anddescribes a novel pharmaceutical preparation in the form of a suspensioncomprising an acid-labile active ingredient, in particular an acid-labileproton pump inhibitor. The invention also relates to processes for producingthe suspension. The suspension is particularly suitable for administering acid-labile active ingredients to people who have difficulty taking solid dosageforms such as tablets or capsules.